Profound Medical Stock Forward View - 20 Period Moving Average
| PROF Stock | USD 5.55 -0.06 -1.07% |
Momentum
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter -0.27 | EPS Estimate Current Year -0.96 | EPS Estimate Next Year -0.78 | Wall Street Target Price 11.9 | EPS Estimate Current Quarter -0.27 |
The hype view outlines Profound Medical's attention response alongside peer coverage. This view uses options positioning and short interest to outline sentiment around Profound Medical.
Short Interest Panel - Profound Medical
A declining trend in Profound Medical's short interest is generally a bullish signal, suggesting that bearish investors are reducing exposure to Profound.
200 Day MA 6.1414 | Short Percent 0.0437 | Short Ratio 6.03 | Shares Short Prior Month 1.4 M | 50 Day MA 7.3212 |
Profound Relative Strength
The 20 Period Moving Average forecasted value of Profound Medical Corp on the next trading day is expected to be 6.72 with a mean absolute deviation of 0.65 and the sum of the absolute errors of 26.55.Profound Medical Corp Hype-Price Mapping
The Profound Medical Corp sentiment model analyzes how public information - from earnings calls to social media chatter - shapes investor behavior and, ultimately, Profound Medical's stock price.
Profiting from Profound Medical's sentiment mispricings requires combining sentiment signals with fundamental analysis. Sentiment alone is insufficient; it must be validated by the underlying business quality of Profound Medical.
Profound Medical Implied Volatility | 4.19 |
Changes in Profound Medical's implied volatility directly affect the price of all Profound Medical options regardless of the direction of the underlying stock. A volatility expansion benefits option holders; a contraction benefits sellers.
The 20 Period Moving Average forecasted value of Profound Medical Corp on the next trading day is expected to be 6.72 with a mean absolute deviation of 0.65 and the sum of the absolute errors of 26.55.Profound Medical after-hype prediction price | $ 5.44 |
The sentiment summary complements forecasting and technical views with analyst estimates and earnings data.
Cross-verify projections for Profound Medical using Historical Fundamental Analysis of Profound Medical. The analysis adds historical context for the projection set.Rule 16 Reference for the current Profound contract - Market Context
Based on Rule 16, the market-implied daily move for 2026-03-20 options is about 0.26%. At a recent price around $ 5.55, the implied daily move is approximately $ 0.0145 , which is informational only.
Open Interest Overview: 2026-03-20 Profound Contracts
Open interest data captures outstanding Profound Medical option contracts and helps map participation over time.
Profound Medical Additional Predictive Modules
Most predictive techniques to examine Profound price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Profound using various technical indicators. When you analyze Profound charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Profound Medical 20 Period Moving Average Price Forecast For the 13th of March 2026
Given 90 days horizon, the 20 Period Moving Average forecasted value of Profound Medical Corp on the next trading day is expected to be 6.72 with a mean absolute deviation of 0.65 , mean absolute percentage error of 0.66 , and the sum of the absolute errors of 26.55 .Please note that although there have been many attempts to predict Profound Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Profound Medical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Profound Medical Stock Forecast Pattern
| Backtest Profound Medical | Profound Medical Price Prediction | Research Analysis |
Profound Medical Forecasted Value
This next-day forecast for Profound Medical Corp uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Profound Medical stock data series using in forecasting. Note that when a statistical model is used to represent Profound Medical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 80.937 |
| Bias | Arithmetic mean of the errors | 0.3503 |
| MAD | Mean absolute deviation | 0.6475 |
| MAPE | Mean absolute percentage error | 0.1002 |
| SAE | Sum of the absolute errors | 26.547 |
Investors who believe in mean reversion view Profound Medical's price extremes not as permanent states but as temporary dislocations that create opportunities for disciplined, contrarian capital allocation.
Profound Medical After-Hype Price Density Analysis
The shape of Profound Medical's price distribution after major news events tends to be skewed, with larger potential moves to the downside than to the upside for established companies like Profound Medical. This asymmetry is a key input for options pricing and risk management.
Next price density |
| Expected price to next headline |
Profound Medical Estimiated After-Hype Price Volatility
By studying Profound Medical's historical news reactions, we generate empirical estimates of the price boundaries that follow significant headlines. Profound Medical's after-hype downside and upside margins for the prediction period are 0.27 and 10.61, respectively. These estimates are most reliable when Profound Medical's news reaction patterns have been consistent over multiple events.
Current Value
The after-hype framework applied to Profound Medical Corp assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Profound Medical Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Profound Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Profound Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Profound Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 5.17 | 0.16 | 0.01 | 10 Events | 6 Events | In 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
5.55 | 5.44 | 2.68 |
|
Profound Medical Hype Timeline
Profound Medical Corp is at this time traded for 5.55. The company has historical hype elasticity of -0.16, and average elasticity to hype of competition of -0.01. Profound is estimated to decline in value after the next headline, with the price expected to drop to 5.44. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.68%, whereas the daily expected return is at this time at -0.31%. The volatility of related hype on Profound Medical is about 13605.26%, with the expected price after the next announcement by competition of 5.54. About 45.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.32. Profound Medical Corp last dividend was issued on the 16th of October 2019. The company completed a 1:10 stock split on 16th of October 2019. Given the investment horizon of 90 days the next estimated press release will be in 10 days. Cross-verify projections for Profound Medical using Historical Fundamental Analysis of Profound Medical. The analysis adds historical context for the projection set.Profound Medical Related Hype Analysis
News about regulatory changes, technological disruptions, or macroeconomic shifts can affect Profound Medical's entire competitive landscape simultaneously. Monitoring peer reactions to such events helps investors anticipate Profound Medical's likely response.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TLSI | TriSalus Life Sciences | 0.54 | 9 per month | 0.00 | -0.13 | 5.49 | -7.79 | 26.66 | |
| MXCT | MaxCyte | -0.06 | 8 per month | 0.00 | -0.25 | 6.10 | -6.96 | 16.23 | |
| CATX | Perspective Therapeutics | 0.17 | 10 per month | 4.93 | 0.16 | 11.81 | -8.83 | 77.44 | |
| LNSR | LENSAR Inc | -0.16 | 5 per month | 1.62 | 0.05 | 2.58 | -2.92 | 9.35 | |
| AVR | Anteris Technologies Global | -0.08 | 10 per month | 3.22 | 0.15 | 9.42 | -5.99 | 25.09 | |
| NNOX | Nano X Imaging | -0.19 | 7 per month | 0.00 | -0.13 | 6.31 | -6.23 | 15.50 | |
| PRE | Prenetics Global | -0.62 | 9 per month | 4.16 | 0.13 | 13.33 | -7.28 | 27.11 | |
| STIM | Neuronetics | -0.06 | 10 per month | 5.89 | 0.01 | 10.95 | -9.09 | 35.51 | |
| OWLT | Owlet Inc | -0.04 | 7 per month | 0.00 | -0.15 | 6.12 | -11.88 | 49.11 | |
| ARMP | Armata Pharmaceuticals | 0.12 | 2 per month | 4.60 | 0.18 | 14.07 | -7.66 | 34.69 |
Other Forecasting Options for Profound Medical
Investors at all stages of experience who consider Profound must develop an understanding of Profound Medical's price dynamics. The noise embedded in Profound Stock price charts can create misleading signals and skew investment decisions.Profound Medical Related Equities
The following equities are related to Profound Medical within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Profound Medical against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Profound Medical Market Strength Events
Market strength indicators applied to Profound Medical stock give investors a structured view of the security's momentum relative to the overall market. Using these indicators, traders can refine their timing when entering or exiting positions in Profound Medical Corp.
Profound Medical Risk Indicators
Evaluating Profound Medical's risk indicators is an important step in accurately forecasting its price and assessing the suitability of an investment. Understanding the risk profile of Profound Medical's allows investors to make more informed decisions about position sizing and risk.
| Mean Deviation | 3.16 | |||
| Standard Deviation | 5.06 | |||
| Variance | 25.59 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Profound Medical
Coverage intensity for Profound Medical Corp matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Profound Medical Short Properties
Short sentiment tied to Profound Medical Corp matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 30.2 M | |
| Cash And Short Term Investments | 81.8 M |
More Resources for Profound Stock Analysis
A comprehensive view of Profound Medical Corp starts with financial statements and ratio context. Ratios and trend metrics help frame Profound Medical's operating context. Highlighted below are reports that provide context for Profound Medical Corp Stock:Cross-verify projections for Profound Medical using Historical Fundamental Analysis of Profound Medical. The analysis adds historical context for the projection set. Analysis related to Profound Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Earnings Share -1.32 | Revenue Per Share | Quarterly Revenue Growth 0.431 | Return On Assets | Return On Equity |
Understanding Profound Medical Corp includes distinguishing between market value and book value, where book value reflects Profound accounting equity. Profound Medical's market capitalization is 196.34 M. With a P/B ratio of 6.13, the market values Profound Medical well above its book equity. Enterprise value stands at 174.69 M. Intrinsic value is an estimate of what Profound Medical's fundamentals imply, and it may differ from market and book figures. Analytical frameworks help compare those viewpoints.
The concept of value for Profound Medical differs from its quoted price, since each reflects a different lens. For Profound Medical, key inputs include a P/B ratio of 6.13, a profit margin of -2.64%, ROE of -67.11%, and revenue of 16.1 M. Market price reflects the current exchange level formed by active bids and offers.